{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:22:06Z","timestamp":1794345726411,"version":"4.9.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clinre.2026.102939","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:54:42Z","timestamp":1791960882000},"page":"102939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic hepatocellular cholestasis: an update"],"prefix":"10.1016","volume":"50","author":[{"given":"Antoine","family":"Gardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Pouillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Almes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1546-3193","authenticated-orcid":false,"given":"Emmanuel","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jacquemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2026.102939_bib0001","series-title":"Comprehensive Physiology","first-page":"1035","article-title":"Bile Formation and Secretion","author":"Boyer","year":"2013"},{"key":"10.1016\/j.clinre.2026.102939_bib0002","series-title":"Liver Disease in Children","first-page":"101","article-title":"Approach to the infant with cholestasis","author":"Feldman","year":"2014"},{"key":"10.1016\/j.clinre.2026.102939_bib0003","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.32437","article-title":"Cholestatic liver diseases of genetic etiology: Advances and controversies","volume":"75","author":"Ibrahim","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","article-title":"Systematic review of progressive familial intrahepatic cholestasis","volume":"43","author":"Baker","year":"2019","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0005","unstructured":"EPAR\u202f: Assessment Report. BYLVAY. Procedure No. EMA\/H\/C\/004691\/0000 n.d."},{"key":"10.1016\/j.clinre.2026.102939_bib0006","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/MPG.0000000000001546","article-title":"Attempt to Determine the Prevalence of Two Inborn Errors of Primary Bile Acid Synthesis: Results of a European Survey","volume":"64","author":"Jahnel","year":"2017","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0007","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.23539","article-title":"ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history","volume":"51","author":"Davit-Spraul","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinre.2026.102939_bib0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.510260121","article-title":"Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity","volume":"26","author":"Bull","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hep.26974","article-title":"MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease: Hepatology","volume":"60","author":"Girard","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0011","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00439-006-0232-z","article-title":"Clinical and molecular genetic features of ARC syndrome","volume":"120","author":"Gissen","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0012","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/brain\/awab206","article-title":"Biallelic variants in VPS50 cause a neurodevelopmental disorder with neonatal cholestasis","volume":"144","author":"Schneeberger","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.clinre.2026.102939_bib0013","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2018.01.009","article-title":"Loss-of-Function Mutations in UNC45A Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility","volume":"102","author":"Esteve","year":"2018","journal-title":"The American Journal of Human Genetics"},{"key":"10.1016\/j.clinre.2026.102939_bib0014","article-title":"A novel mechanism involving USP53-regulated BSEP trafficking underlies low-GGT intrahepatic cholestasis","author":"Ding","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(05)83280-9","article-title":"A new cause of progressive intrahepatic cholestasis: 3\u03b2-Hydroxy-C27-steroid dehydrogenase\/isomerase deficiency","volume":"125","author":"Jacquemin","year":"1994","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.clinre.2026.102939_bib0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1432-1033.1997.00039.x","article-title":"Differential Interaction of Bile Acids from Patients with Inborn Errors of Bile Acid Synthesis with Hepatocellular Bile Acid Transporters","volume":"244","author":"Stieger","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.clinre.2026.102939_bib0017","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48431","article-title":"MRGPRX4 is a bile acid receptor for human cholestatic itch","volume":"8","author":"Yu","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.clinre.2026.102939_bib0018","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1016\/j.cell.2024.10.001","article-title":"Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2026.102939_bib0019","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10545-010-9259-3","article-title":"Disorders of bile acid synthesis","volume":"34","author":"Clayton","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/HEP.0000000000000828","article-title":"Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency\u2013related cholestasis","volume":"80","author":"Lal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0022","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1053\/j.gastro.2004.07.022","article-title":"Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: A tight junction disease","volume":"127","author":"Hadj-Rabia","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0023","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","article-title":"Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants","volume":"21","author":"Maddirevula","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.clinre.2026.102939_bib0024","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/hep.30841","article-title":"Plectin Mutations in Progressive Familial Intrahepatic Cholestasis","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"De Vree","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clinre.2026.102939_bib0026","series-title":"Liver Disease in Children","first-page":"216","article-title":"Alagille syndrome","author":"Kamath","year":"2014"},{"key":"10.1016\/j.clinre.2026.102939_bib0027","series-title":"GeneReviews\u00ae [Internet]","article-title":"Alagille Syndrome","author":"Spinner","year":"2000"},{"key":"10.1016\/j.clinre.2026.102939_bib0028","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jhep.2016.07.017","article-title":"Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis","volume":"65","author":"Grammatikopoulos","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0029","article-title":"Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis","author":"Luan","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101231","article-title":"Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations","volume":"26","author":"Maddirevula","year":"2024","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.clinre.2026.102939_bib0031","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jmg-2025-110658","article-title":"Biallelic pathogenic TULP3 variants presenting as neonatal cholestasis, liver fibrosis and neurological manifestations","volume":"62","author":"Li","year":"2025","journal-title":"J Med Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0032","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cge.14412","article-title":"Biallelic ANKS6 null variants cause notable extrarenal phenotypes in a nephronophthisis patient and lead to hepatobiliary abnormalities by YAP1 deficiency","volume":"104","author":"Liu","year":"2023","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.clinre.2026.102939_bib0033","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0016-5085(99)70287-8","article-title":"Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis","volume":"117","author":"Jansen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0034","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2004.04.065","article-title":"Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11","volume":"127","author":"Van Mil","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(01)00299-9","article-title":"Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum","volume":"36","author":"Van Ooteghem","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0036","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"Van Wessel","year":"2020","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0037","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.27872","article-title":"Hepatocellular carcinoma associated with tight-junction protein 2 deficiency","volume":"62","author":"Zhou","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0038","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0039","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-012-1202-6","article-title":"Aspects of liver pathology in adult patients with MDR3\/ABCB4 gene mutations","volume":"460","author":"Wendum","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clinre.2026.102939_bib0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2012.01.025","article-title":"ABCB4\/MDR3 gene mutations and cholangiocarcinomas","volume":"57","author":"Tougeron","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100844","article-title":"Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy","author":"Gonzales","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1016\/j.clinre.2026.102939_bib0042","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","article-title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants","volume":"67","author":"Dr\u00f6ge","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fgstr.2025.1435168","article-title":"Case Report: A rare case of familial progressive cholestasis type 10 in an adult with heterozygous MYO5B variant","volume":"4","author":"Huimin","year":"2025","journal-title":"Front Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102939_bib0044","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cgh.2025.07.031","article-title":"Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease","volume":"24","author":"Scaravaglio","year":"2026","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: A study of 156 consecutive patients: Hepatology","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11626-x","article-title":"An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy","volume":"7","author":"Dixon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2026.102939_bib0047","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","article-title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing","volume":"53","author":"Vitale","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102939_bib0048","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.70229","article-title":"Rare Variants in PFIC-Related Genes Among Adults With Intrahepatic Cholestasis","author":"Hirose","year":"2026","journal-title":"Hepatology Research"},{"key":"10.1016\/j.clinre.2026.102939_bib0049","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.mpg.0000184429.34001.68","article-title":"Heterozygous Bile Salt Export Pump Deficiency: A Possible Genetic Predisposition to Transient Neonatal Cholestasis","volume":"42","author":"Hermeziu","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/MPG.0b013e3181cd2725","article-title":"Heterozygous FIC1 Deficiency: A New Genetic Predisposition to Transient Neonatal Cholestasis","volume":"50","author":"Jacquemin","year":"2010","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0051","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-015-1110-z","article-title":"ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression","volume":"51","author":"Degiorgio","year":"2016","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102939_bib0052","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.clinre.2026.102939_bib0053","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","volume":"64","author":"Fawaz","year":"2017","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0056","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe Bile Salt Export Pump Deficiency: 82 Different ABCB11 Mutations in 109 Families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/10935266261429304","article-title":"Pathology of Progressive Familial Intrahepatic Cholestasis: An update","volume":"29","author":"Mitra","year":"2026","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.clinre.2026.102939_bib0058","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/diagnostics12051169","article-title":"Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis","volume":"12","author":"Almes","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.clinre.2026.102939_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101183","article-title":"PFMG2025\u2013integrating genomic medicine into the national healthcare system in France","volume":"50","author":"Abadie","year":"2025","journal-title":"The Lancet Regional Health - Europe"},{"key":"10.1016\/j.clinre.2026.102939_bib0161","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI2962","article-title":"Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease","volume":"102","author":"Setchell","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2026.102939_bib0162","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MPG.0b013e31815a9911","article-title":"Neonatal Cholestatic Liver Disease in an Asian Patient With a Homozygous Mutation in the Oxysterol 7\u03b1-hydroxylase Gene","volume":"46","author":"Ueki","year":"2008","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0062","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI112915","article-title":"Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids","volume":"79","author":"Clayton","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2026.102939_bib0067","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI113837","article-title":"Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis","volume":"82","author":"Setchell","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2026.102939_bib0071","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s13023-023-02984-z","article-title":"\u22064-3-oxo-5\u03b2-reductase deficiency: favorable outcome in 16 patients treated with cholic acid","volume":"18","author":"Gardin","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0146","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/hep.1840180513","article-title":"Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency)","volume":"18","author":"Daugherty","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0163","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MPG.0000000000001730","article-title":"Severe Neonatal Cholestasis in Cerebrotendinous Xanthomatosis: Genetics, Immunostaining, Mass Spectrometry","volume":"65","author":"Gong","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2026.102939_bib0164","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1021211520034","article-title":"Mutations in the sterol 27-hydoxylase gene CYP27A1 cause hepatitis of infancy as well as cerebrotendinous xanthomatosis","volume":"25","author":"Clayton","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jacl.2020.12.004","article-title":"Cholestasis as a dominating symptom of patients with CYP27A1 mutations: An analysis of 17 Chinese infants","volume":"15","author":"Zhang","year":"2021","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.clinre.2026.102939_bib0166","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bbamcr.2006.09.001","article-title":"Peroxisomes and bile acid biosynthesis","volume":"1763","author":"Ferdinandusse","year":"2006","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.clinre.2026.102939_bib0079","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng0398-219","article-title":"A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis","volume":"18","author":"Bull","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0072","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0057","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0091","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/MPG.0000000000002670","article-title":"NR1H4-related Progressive Familial Intrahepatic Cholestasis 5: Further Evidence for Rapidly Progressive Liver Failure","volume":"70","author":"Himes","year":"2020","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0092","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.12998\/wjcc.v9.i15.3631","article-title":"Progressive familial intrahepatic cholestasis \u2014 farnesoid X receptor deficiency due to NR1H4 mutation: A case report","volume":"9","author":"Czubkowski","year":"2021","journal-title":"WJCC"},{"key":"10.1016\/j.clinre.2026.102939_bib0097","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.28779","article-title":"MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease","volume":"65","author":"Gonzales","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0099","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/0115733963264010231213103328","article-title":"Newly Described Mutations of the UNC45A Gene in Infants with Jaundice and Pruritus","volume":"21","author":"Degtyareva","year":"2025","journal-title":"CPR"},{"key":"10.1016\/j.clinre.2026.102939_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104693","article-title":"UNC45A-related osteo-oto-hepato-enteric syndrome in a Chinese neonate","volume":"66","author":"Kong","year":"2023","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/j.clinre.2026.102939_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.05.037","article-title":"Aagenaes syndrome\/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5\u2019-untranslated region of UNC45A","author":"Almaas","year":"2023","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0102","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.64004","article-title":"A New Unc45a 5\u2019utr Variant In Patients With Aagenaes Syndrome","volume":"197","author":"Tan","year":"2025","journal-title":"American J of Med Genetics Pt A"},{"key":"10.1016\/j.clinre.2026.102939_bib0108","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng1325","article-title":"Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis\u2013renal dysfunction\u2013cholestasis (ARC) syndrome","volume":"36","author":"Gissen","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0109","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng.538","article-title":"Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization","volume":"42","author":"Cullinane","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0104","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/liv.14422","article-title":"Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2026.102939_bib0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/MPG.0000000000002926","article-title":"Cholestasis Due to USP53 Deficiency","volume":"72","author":"Bull","year":"2021","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s10038-020-0811-1","article-title":"New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin","volume":"66","author":"Alhebbi","year":"2021","journal-title":"J Hum Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-210712","article-title":"Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report","volume":"9","author":"Molera","year":"2022","journal-title":"JND"},{"key":"10.1016\/j.clinre.2026.102939_bib0112","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114563","article-title":"A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis","volume":"13","author":"Pan","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clinre.2026.102939_bib0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jpeds.2020.01.064","article-title":"Biallelic Mutations in the LSR Gene Cause a Novel Type of Infantile Intrahepatic Cholestasis","volume":"221","author":"Uehara","year":"2020","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.clinre.2026.102939_bib0116","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1582769","article-title":"The role of LSR gene variants in early onset intrahepatic cholestasis: a case series with treatment options","volume":"13","author":"Ohlsson","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clinre.2026.102939_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2025.102674","article-title":"GGT-normal cholestasis associated with LSR deficiency: A potential new subtype of PFIC","volume":"49","author":"Cosar","year":"2025","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0118","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/cge.14611","article-title":"Novel PLEC variants associated with infantile cholestasis","volume":"106","author":"Kor-anantakul","year":"2024","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.clinre.2026.102939_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2018.06.006","article-title":"Inborn Errors of Bile Acid Metabolism","volume":"22","author":"Heubi","year":"2018","journal-title":"Clinics in Liver Disease"},{"key":"10.1016\/j.clinre.2026.102939_bib0061","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1210\/jc.2002-021580","article-title":"Molecular Genetics of 3\u03b2-Hydroxy-\u03945-C27-Steroid Oxidoreductase Deficiency in 16 Patients with Loss of Bile Acid Synthesis and Liver Disease","volume":"88","author":"Cheng","year":"2003","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.clinre.2026.102939_bib0063","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.gastro.2009.07.043","article-title":"Oral Cholic Acid for Hereditary Defects of Primary Bile Acid Synthesis: A Safe and Effective Long-term Therapy","volume":"137","author":"Gonzales","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0064","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MPG.0000000000001657","article-title":"Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders","volume":"65","author":"Heubi","year":"2017","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13023-021-02041-7","article-title":"Genetic spectrum and clinical characteristics of 3\u03b2-hydroxy-\u03945-C27-steroid oxidoreductase (HSD3B7) deficiency in China","volume":"16","author":"Zhao","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0066","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13023-018-0920-5","article-title":"Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood","volume":"13","author":"Gonzales","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0068","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0022-3476(94)70310-8","article-title":"\u03944-3-Oxosteroid 5\u03b2-reductase deficiency causing neonatal liver failure and hemochromatosis","volume":"124","author":"Shneider","year":"1994","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.clinre.2026.102939_bib0070","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.52.10.1494","article-title":"Mutations in SRD5B1 (AKR1D1), the gene encoding 4-3-oxosteroid 5 -reductase, in hepatitis and liver failure in infancy","volume":"52","author":"Lemonde","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2026.102939_bib0069","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/gut.38.4.623","article-title":"Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid","volume":"38","author":"Clayton","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2026.102939_bib0073","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in Bile Salt Export Pump (ABCB11) in Two Children with Progressive Familial Intrahepatic Cholestasis and Cholangiocarcinoma","volume":"150","author":"Scheimann","year":"2007","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.clinre.2026.102939_bib0074","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000860","article-title":"Preemptive liver transplantation is essential for patients with severe BSEP deficiency","author":"Shagrani","year":"2026","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.clinre.2026.102939_bib0075","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/ncomms4850","article-title":"Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency","volume":"5","author":"Iannelli","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinre.2026.102939_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100626","article-title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","volume":"5","author":"Felzen","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1016\/j.clinre.2026.102939_bib0077","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa0901075","article-title":"Recurrence of Bile Salt Export Pump Deficiency after Liver Transplantation","volume":"361","author":"Jara","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102939_bib0078","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep.28311","article-title":"Bile salt export pump-reactive antibodies form a polyclonal, multi-inhibitory response in antibody-induced bile salt export pump deficiency","volume":"63","author":"Stindt","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118656119","article-title":"Structural insights into the activation of autoinhibited human lipid flippase ATP8B1 upon substrate binding","volume":"119","author":"Cheng","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clinre.2026.102939_bib0081","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/j.gastro.2008.10.025","article-title":"ATP8B1 Deficiency Disrupts the Bile Canalicular Membrane Bilayer Structure in Hepatocytes, But FXR Expression and Activity Are Maintained","volume":"136","author":"Cai","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0082","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.21212","article-title":"Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport","volume":"44","author":"Paulusma","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0083","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1203\/PDR.0b013e3181c2df16","article-title":"ATPase Class I Type 8B Member 1 and Protein Kinase C \u03b6 Induce the Expression of the Canalicular Bile Salt Export Pump in Human Hepatocytes","volume":"67","author":"Chen","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clinre.2026.102939_bib0084","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1969.02100030114014","article-title":"Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred","volume":"117","author":"Clayton","year":"1969","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.clinre.2026.102939_bib0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2001-19034","article-title":"FIC1 Disease: A Spectrum of Intrahepatic Cholestatic Disorders","volume":"21","author":"Van Mil","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0054","doi-asserted-by":"crossref","first-page":"003","DOI":"10.1055\/s-0031-1272831","article-title":"Progressive Familial Intrahepatic Cholestasis (PFIC) Type 1, 2, and 3: A Review of the Liver Pathology Findings","volume":"31","author":"Morotti","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0086","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31787","article-title":"Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency","author":"van Wessel","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0087","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(03)00286-1","article-title":"Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation","volume":"39","author":"Lykavieris","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0088","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/jlts.2002.34384","article-title":"Intractable diarrhea after liver transplantation for Byler\u2019s disease: Successful treatment with bile adsorptive resin","volume":"8","author":"Egawa","year":"2002","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.clinre.2026.102939_bib0089","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/jpn3.70227","article-title":"Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series","volume":"81","author":"Vogel","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2026.102939_bib0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/children9050669","article-title":"Ileal Bile Acid Transporter Inhibition Reduces Post-Transplant Diarrhea and Growth Failure in FIC1 Disease\u2014A Case Report","volume":"9","author":"Ohlendorf","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.clinre.2026.102939_bib0093","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ng.225","article-title":"MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity","volume":"40","author":"M\u00fcller","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102939_bib0094","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcmgh.2022.04.006","article-title":"A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy","volume":"14","author":"Li","year":"2022","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0095","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.31430","article-title":"Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis","volume":"72","author":"IJzendoorn","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0096","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hep.31002","article-title":"A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations","volume":"72","author":"Overeem","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0098","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154997","article-title":"UNC45A deficiency causes microvillus inclusion disease-like phenotype by impairing myosin VB-dependent apical trafficking","volume":"132","author":"Duclaux-Loras","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2026.102939_bib0103","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1523\/JNEUROSCI.1965-15.2015","article-title":"Progressive Hearing Loss in Mice Carrying a Mutation in Usp53","volume":"35","author":"Kazmierczak","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinre.2026.102939_bib0107","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jpn3.12392","article-title":"Natural course and outcomes of children with ubiquitin-specific protease 53 (USP53)-related genetic chronic cholestasis","volume":"79","author":"Alam","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2026.102939_bib0111","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.clinre.2026.102939_bib0113","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","article-title":"Structural and functional hepatocyte polarity and liver disease","volume":"63","author":"Gissen","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0114","series-title":"Comprehensive Physiology","first-page":"1819","article-title":"Claudins and Other Tight Junction Proteins","author":"G\u00fcnzel","year":"2012"},{"key":"10.1016\/j.clinre.2026.102939_bib0119","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3390\/nu13082785","article-title":"Malnutrition in Pediatric Chronic Cholestatic Disease: An Up-to-Date Overview","volume":"13","author":"Tessitore","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clinre.2026.102939_bib0120","doi-asserted-by":"crossref","unstructured":"Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid `mechanisms of action and clinical use in hepatobiliary disorders\u2019q 2001.","DOI":"10.1016\/S0168-8278(01)00092-7"},{"key":"10.1016\/j.clinre.2026.102939_bib0121","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0122","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic Acid Therapy in Pediatric Patients With Progressive Familial Intrahepatic Cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0123","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/MPG.0000000000003399","article-title":"MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype","volume":"74","author":"Matarazzo","year":"2022","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"10.1016\/j.clinre.2026.102939_bib0124","first-page":"442","article-title":"Use of Rifampin for Severe Pruritus in Children with Chronic Cholestasis","volume":"29","author":"Yerushalmi","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2026.102939_bib0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2024.04.006","article-title":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases","volume":"81","author":"Verkade","year":"2024","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jpedsurg.2011.08.010","article-title":"Normalization of serum bile acids after partial external biliary diversion indicates an excellent long-term outcome in children with progressive familial intrahepatic cholestasis","volume":"47","author":"Schukfeh","year":"2012","journal-title":"Journal of Pediatric Surgery"},{"key":"10.1016\/j.clinre.2026.102939_bib0127","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100782","article-title":"Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis","volume":"5","author":"Thompson","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1016\/j.clinre.2026.102939_bib0129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","article-title":"Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Miethke","year":"2024","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102185","article-title":"Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency","volume":"47","author":"Di Giorgio","year":"2023","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0132","article-title":"Pretreatment serum bile acid composition and predictability of subsequent response to odevixibat in patients with bile salt export pump (BSEP) deficiency","author":"Nomden","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0133","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70524","article-title":"Ileal Bile Acid Transporter Inhibitors in Cholestasis: Potential for More Than Just Paediatrics?","volume":"46","author":"Krishna","year":"2026","journal-title":"Liver International"},{"key":"10.1016\/j.clinre.2026.102939_bib0134","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/apt.70666","article-title":"Review Article: Ileal Bile Acid Transport (IBAT) Inhibitors as an Emerging Treatment for Cholestatic Liver Disease","volume":"64","author":"Peverelle","year":"2026","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2026.102939_bib0135","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102939_bib0136","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1750-1172-9-89","article-title":"Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1","volume":"9","author":"Hasegawa","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2026.102939_bib0137","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1111\/liv.14518","article-title":"Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency","volume":"40","author":"Mareux","year":"2020","journal-title":"Liver International"},{"key":"10.1016\/j.clinre.2026.102939_bib0138","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14839","article-title":"Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants","volume":"41","author":"Ben Saad","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2026.102939_bib0139","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.21630","article-title":"4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps","volume":"45","author":"Hayashi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.27767","article-title":"Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate","volume":"62","author":"Gonzales","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0141","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2012.04.017","article-title":"Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2","volume":"57","author":"Gonzales","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0142","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.23083","article-title":"De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: A novel mechanism of cholestasis\u2020","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0143","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jhep.2010.05.025","article-title":"Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2","volume":"53","author":"Maggiore","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0144","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/lt.23754","article-title":"Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation: Rituximab for Recurrence of BSEP Deficiency After Lt","volume":"19","author":"Lin","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2026.102939_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102139","article-title":"Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab","volume":"47","author":"Wischlen","year":"2023","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102939_bib0147","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3748\/wjg.v25.i7.859","article-title":"\u03944-3-oxosteroid-5\u03b2-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes","volume":"25","author":"Zhang","year":"2019","journal-title":"WJG"},{"key":"10.1016\/j.clinre.2026.102939_bib0148","series-title":"Bile Acids and Their Receptors","first-page":"265","article-title":"Chenodeoxycholic Acid: An Update on Its Therapeutic Applications","volume":"256","author":"Fiorucci","year":"2019"},{"key":"10.1016\/j.clinre.2026.102939_bib0149","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jpn3.12171","article-title":"Failure of cholic acid therapy in a child with a bile acid synthesis defect and harboring plectin mutations","volume":"78","author":"Th\u00e9baut","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2026.102939_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms22010273","article-title":"Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects","volume":"22","author":"Bosma","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.clinre.2026.102939_bib0151","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jhep.2021.12.015","article-title":"Modern therapeutic approaches to liver-related disorders","volume":"76","author":"Gardin","year":"2022","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0152","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2019.03.021","article-title":"Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice","volume":"71","author":"Aronson","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0153","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41467-019-13614-3","article-title":"Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model","volume":"10","author":"Weber","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinre.2026.102939_bib0154","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa2214084","article-title":"Gene Therapy in Patients with the Crigler\u2013Najjar Syndrome","volume":"389","author":"D\u2019Antiga","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102939_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2019000007","article-title":"Gene therapy for hemophilia","volume":"2019","author":"Nathwani","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.clinre.2026.102939_bib0156","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/s41467-025-57383-8","article-title":"Liver fibrosis negatively impacts in vivo gene transfer to murine hepatocytes","volume":"16","author":"Simoni","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinre.2026.102939_bib0157","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.30773","article-title":"Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy","volume":"70","author":"Siew","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102939_bib0158","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1038\/s41467-022-30102-3","article-title":"Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates","volume":"13","author":"Milani","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinre.2026.102939_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100713","article-title":"Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy","author":"Weber","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1016\/j.clinre.2026.102939_bib0160","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","article-title":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4 mouse model of PFIC3","volume":"74","author":"Wei","year":"2021","journal-title":"Journal of Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:35:51Z","timestamp":1794342951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":166,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2210740126001841"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102939","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic hepatocellular cholestasis: an update","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102939"}}